Terms And Conditions
  1. Home
  2. Terms And Conditions
Neuren Pharmaceuticals Limited – Developing...
By ACE Investors / 18 Dec 2020
Read More
Opthea Limited: Focus on Developing and Comme...
By ACE Investors / 15 Dec 2020
Read More
Sigma Healthcare Ltd (ASX: SIG): Reduced depe...
By ACE Investors / 09 Dec 2020
Read More
Biotron Limited: Compounds Show Positive Acti...
By ACE Investors / 04 Dec 2020
Read More
Creso Pharma Limited: Strengthened Its Revenu...
By ACE Investors / 02 Dec 2020
Read More
Clinuvel Pharmaceuticals Limited: Resilient P...
By ACE Investors / 01 Dec 2020
Read More
BWX Limited: Focus on Expanding product Offer...
By ACE Investors / 26 Nov 2020
Read More
Medibank: What you need to know about the pri...
By ACE Investors / 24 Nov 2020
Read More
Immutep Limited: Worldwide Leader in Developi...
By ACE Investors / 23 Nov 2020
Read More
Palla Pharma Limited: Lowest Cost Producer of...
By ACE Investors / 23 Nov 2020
Read More
Regis Healthcare: Will it endure a near term ...
By ACE Investors / 18 Nov 2020
Read More
Osteopore Limited – Encouraging Sales Growt...
By ACE Investors / 16 Nov 2020
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors